13 December 2021 - Deborah Wilkes
Read all about Karo Pharma's recently-announced acquisition of Sylphar International and plans to drive organic growth and internationalisation in this NEWS EXTRA publication from OTCToolbox.
Sweden's Karo Pharma sharpened its focus on consumer healthcare in 2021 by agreeing the acquisition of Belgium’s Sylphar International and hiring experts in the field to drive organic growth and internationalisation. Chief executive officer Christoffer Lorenzen talks about the next steps for the Swedish company.
Download this NEWS EXTRA publication today to find out more about Karo Pharma's approach including:
- Acquisitions strategy
- E-commerce and digital marketing
- Hiring consumer healthcare experts
- Approach to innovation
- Ambitious growth targets
- Acquisitions to date
- Financial performance
The News Extra is available to purchase and download immediately from the OTCToolbox website. You can make sure your team is well informed through a Multiple User Licence or a Global Licence. It is available free to people with an Annual Subscription to the OTCToolbox website.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.